Dutch Argenx SE Acquires Forte Biosciences for $2.2 Billion; Shares Surge 39%
Forte Biosciences shares surged nearly 39% in pre-market trading after the company agreed to be acquired by Dutch biotech firm Argenx SE for $2.2 billion in a premium deal. The acquisition represents a significant premium to Forte's recent market price.
Forte Biosciences shares surged nearly 39% in pre-market trading. The company is being acquired by Dutch biotech company Argenx SE for $2.2 billion in a premium acquisition.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Biotechnology, with intensity 60/100 and 80% confidence over a short term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.